7 MB
|
![]() |
EGFR Mutation Analysis – Performance Evaluation of Blood Collection Tubes for ccfDNA Stabilization (Ullius, AMP 2019) | 768115 | Posters |
---|---|---|---|---|
6 MB
|
![]() |
Precision and Robustness of the PAXgene Blood ccfDNA Workflow (Krenz, AMP 2019) | 768115 | Posters |
6 MB
|
![]() |
Comparison of Hemolysis in Circulating Cell-free DNA Stabilization Tubes (Hailemariam, AMP 2019) | 768115 | Posters |
Link | PAXgene Blood ccfDNA Tube RUO SDS | 768115 | Safety Data Sheets | |
Link | PAXgene Blood DNA Tube RUO SDS | 761115 | Safety Data Sheets | |
Link | For questions about the PAXgene Tissue RNA QIAcube protocol, please contact us. | 766134 | Handbooks | |
904 KB
|
![]() |
Save Time and Resources — Primary Tube Handling Using PAXgene Blood ccfDNA Tubes | 768536 | Brochures |
852 KB
|
![]() |
Shortened Workflow Processing PAXgene Blood ccfDNA Tubes Directly with the QIAsymphony PAXgene Blood ccfDNA Kit | 768536 | Technical Notes |
Link | Groelz, D. et al. (2018) Liquid biopsy preservation solutions for standardized preanalytical workflows – Venous whole blood and plasma. Curr. Pathobiol. Rep. 6, 275. doi: 10.1007/s40139-018-0180-z | 768536 | References | |
Link | Solakoglu, Ö. et al (2019) Characterization of circulating DNA in plasma of patients after allogeneic bone grafting. Clin. Oral Investig. [Epub ahead of print] doi: 10.1007/s00784-019-02867-3 | 768115 | References | |
5 MB
|
![]() |
Verification of a Complete Sample to Insight Liquid Biopsy Workflow – NGS of ccfDNA From Stabilized Blood (Krenz, AACR 2018) | 768536 | Posters |
Link | Schmidt, B. et al. (2017) Liquid biopsy – Performance of the PAXgene Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients. Clin. Chim. Acta. 469, 94. | 768536 | References | |
7 MB
|
![]() |
Performance Evaluation of Collection/Stabilization/Purification Systems for Liquid Biopsy Cancer Biomarker Applications (Groelz, AMP 2017) | 768536 | Posters |
4 MB
|
![]() |
A Shortened Automated Workflow for Processing Plasma Directly From Primary Blood Collection Tubes Reduces Turnaround Time and Risk of Sample Mix-up in ccfDNA Based Applications (Voss CNAPS 2017) | 768536 | Posters |
3 MB
|
![]() |
Cell-free DNA Quality and Quantity Assessment – A Method Comparison (Ullius, CNAPS 2019) | 768115 | Posters |